Luis Miguel Cotamo
Papers
2
Total Citations
6
H-Index
2
About
Luis Miguel Cotamo is a thoracic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques and perioperative care for lung cancer patients. His primary research areas include enhanced recovery after surgery (ERAS) protocols, robotic-assisted thoracoscopic surgery, and neoadjuvant chemoimmunotherapy for non-small cell lung cancer (NSCLC). Cotamo’s most impactful contribution is demonstrating that a rigorous ERAS protocol can safely enable postoperative day 1 discharge following robotic thoracoscopic anatomic lung resections—a finding that achieved a tenfold increase in early discharge rates, as reported in his 2023 study (4 citations). This work has practical implications for reducing hospital stays and improving patient recovery. More recently, his 2025 investigation into neoadjuvant chemoimmunotherapy for locally advanced NSCLC (2 citations) adds to the growing evidence that combining immunotherapy with chemotherapy before surgery yields higher pathologic complete response rates. Cotamo’s research bridges the gap between clinical trial findings and real-world single-institution outcomes, offering actionable insights for thoracic surgical teams. His focus on optimizing both surgical technique and perioperative protocols positions him as a contributor to the evolving standard of care in thoracic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2